MeRes-‐1 Dr Ashok Seth

Recommendations

Info

Disclosure Statement of Financial Interest Within the past 12 months, I, Dr Ashok Seth, have had a financial interest/arrangement or affilia9on with the organiza9on(s) listed below. Affilia9on/Financial Rela9onship Company • Consul9ng Fees/Honoraria • Consul9ng Fees/Honoraria • Meril Life Sciences • AbboH Vascular
Background BRS are now a reality in the treatment of coronary artery disease. Current gen BRS is not a ‘ user friendly device ‘ and hence difficult to apply to the real world pa9ent popula9on • Thick struts, high profile • Special Jps and tricks of implantaJon • Limited expansion characterisJcs • Limited accessibility to side branches • Low radiopacity • Uncertain radial strength • Concerns regarding scaffold thrombosis • Limited sizes of lengths and diameters NEXT GENERATION Devices Are Needed!
Page 1: Monday, 31 st October 2016, 12:
Page 5 and 6: MeRes100 - BRS Strut Thickness,
Page 7 and 8: Key Eligibility Criteria Key In
Page 9 and 10: Study Leadership • PI - Dr.
Page 11 and 12: Baseline Demographics Variable A
Page 13 and 14: Primary Clinical endpoint at 6
Page 15 and 16: QCA Analysis - Angio Subset An
Page 17 and 18: CFD Curve for Late Lumen Loss
Page 19 and 20: Scaffold Implant and Post-‐D
Page 21 and 22: Final Result and Late Follow-
Page 23 and 24: A B C D A B C D MLA: 7.41
Page 25 and 26: CONCLUSIONS • MeRes-‐I tria

MeRes-­‐1 Dr Ashok Seth

Create successful ePaper yourself

Delete template?

Save as template?

MeRes-‐1 Dr Ashok Seth